SCD and metabolic dysfunction-associated steatotic liver disease: Moreover, we observed that HFD-induced NAFLD was associated with significant changes in Scd1 protein dimerization, which was reverted by the use of clofibrate, a powerful PPAR alpha agonist that was also able to improve fat accumulation in hepatocytes.